Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Moskowitz

Showing results (291-300 of 298) with videos related to

Pageof 30
Sort By:
You have reached the last page of results.This site can display upto 298 results.
The New England Journal of Medicine|April 5, 2016
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral RegurgitationRobert E Michler, Peter K Smith, Michael K Parides, et al.
The New England Journal of Medicine|April 5, 2016
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac SurgeryA Marc Gillinov, Emilia Bagiella, Alan J Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin LymphomaAlison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Journal of the American Academy of Dermatology|April 8, 2025
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndromeAmrita Goyal, Daniel O'Leary, Bouthaina Dabaja, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Transplantation and Cellular Therapy|September 2, 2024
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary SyndromeAmrita Goyal, Daniel O'Leary, Bouthaina Dabaja, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 30

Showing results (291-300 of 298) with videos related to

Sort By:
Pageof 30
You have reached the last page of results.This site can display upto 298 results.
The New England Journal of Medicine|April 5, 2016
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral RegurgitationRobert E Michler, Peter K Smith, Michael K Parides, et al.
The New England Journal of Medicine|April 5, 2016
Rate Control versus Rhythm Control for Atrial Fibrillation after Cardiac SurgeryA Marc Gillinov, Emilia Bagiella, Alan J Moskowitz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 25, 2021
Phase II Trial of Pembrolizumab Plus Gemcitabine, Vinorelbine, and Liposomal Doxorubicin as Second-Line Therapy for Relapsed or Refractory Classical Hodgkin LymphomaAlison J Moskowitz, Gunjan Shah, Heiko Schöder, et al.
Journal of the American Academy of Dermatology|April 8, 2025
ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sézary syndromeAmrita Goyal, Daniel O'Leary, Bouthaina Dabaja, et al.
American Journal of Respiratory and Critical Care Medicine|September 13, 2022
A Randomized Trial of Mesenchymal Stromal Cells for Moderate to Severe Acute Respiratory Distress Syndrome from COVID-19Michael E Bowdish, Christina E Barkauskas, Jessica R Overbey, et al.
Transplantation and Cellular Therapy|September 2, 2024
ASTCT and USCLC Clinical Practice Recommendations for Allogeneic Stem Cell Transplant in Mycosis Fungoides and Sézary SyndromeAmrita Goyal, Daniel O'Leary, Bouthaina Dabaja, et al.
Blood|December 10, 2025
CXCL9 as a novel prognostic marker to identify high-risk adults with hemophagocytic lymphohistiocytosisJoseph M Rocco, Joseph H Oved, Rikita J Patel, et al.
Blood Advances|June 30, 2026
Zanubrutinib, Obinutuzumab, and Venetoclax in CLL: Long-Term Follow Up, MRD Kinetics, Retreatment, T-Cell Profiling, PKsJacob D Soumerai, Meghan C Thompson, Ahmet Dogan, et al.
Pageof 30